Development and trafficking of type 1 and type 17 mucosal-associated invariant T...
Development and trafficking of type 1 and type 17 mucosal-associated invariant T cells
Mucosal-associated invariant T (MAIT) cells colonize mucosal tissues where they become tissue-resident and have important protective and homeostatic functions. MAIT cells are selected in the thymus by microbial metabolites present...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
M6ATCELL
Exploiting fundamental insights of m6A methylation on CD8 T...
235K€
Cerrado
Th17 tissue metab
Metabolic imprinting of Th17 cells in disease pathogenesis
266K€
Cerrado
CNS2023-143622
Inmunidad, infección e inmunoterapia
168K€
Cerrado
SAF2015-74561-JIN
FUNCION DE MINCLE EN LA MODULACION DE LA RESPUESTA A LOS COM...
206K€
Cerrado
mirSKIN
The role of miRNAs in the regulation of the generation and m...
231K€
Cerrado
PID2020-116291RB-I00
CARACTERIZACION DE MECANISMOS MOLECULARES IMPLICADOS EN DESA...
284K€
Cerrado
Información proyecto MAIT-TraDe
Duración del proyecto: 36 meses
Fecha Inicio: 2023-08-10
Fecha Fin: 2026-08-31
Líder del proyecto
INSTITUT CURIE
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
196K€
Descripción del proyecto
Mucosal-associated invariant T (MAIT) cells colonize mucosal tissues where they become tissue-resident and have important protective and homeostatic functions. MAIT cells are selected in the thymus by microbial metabolites presented by MHC-related protein 1 (MR1) on thymocytes thereby acquiring an effector phenotype (type 1 or 17). This project aims at elucidating mechanisms that regulate the last stages of thymic MAIT cell development, including their egress, and identify cues necessary for tissue colonization. Specifically, we will couple transcriptomics and thymus transplantation models to analyze canonical thymic MAIT cell development, thereby identifying new regulators of the MAIT1/17 fates, as well as to identify MAIT cells that recently exited the thymus and seeded mucosal organs, thereby identifying new regulators of tissue adaptation. These targets will be functionally tested in models combining CRISPR/Cas9 encoded by lentivirus with bone-marrow chimeras or adoptive transfers. Additionally, we will determine the identity and dynamics of MAIT cells exiting the thymus to colonize tissues by combining different experimental approaches including in vivo EdU/biotin labeling, thymectomy and blockage of thymus egress. Lastly, we will address whether MR1–microbial metabolites are required for the maintenance of MAIT cells in tissues at steady-state using mono-colonization/decolonization of germ-free mice and by conditionally ablating Mr1. Overall, this work will uncover fundamental mechanisms underlying MAIT cell development and tissue colonization. Albeit outside the scope of this work, it is possible that the mechanisms uncovered here may have implications in other innate-like T cells or for the establishment of mainstream tissue-resident T cells.